Status:

COMPLETED

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Lead Sponsor:

Tanabe Pharma Corporation

Conditions:

Chronic Kidney Disease

Hyperphosphatemia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a phase III multi-centre study in three periods: the first period is a phosphate binder washout for 4 weeks, the second period is an open-label, randomised, parallel group, flexible dose, the ...

Eligibility Criteria

Inclusion

  • Male or female, 18 years of age or over
  • Clinically stable haemodialysis or peritoneal dialysis
  • Stable phosphate control
  • On a stabilised phosphorus diet
  • Female and of child-bearing potential have a negative serum pregnancy test.
  • Male subjects must agree to use appropriate contraception.

Exclusion

  • Current clinically significant medical comorbidities, which may substantially compromise subject safety, or expose them to undue risk, or interfere significantly with study procedures and which, in the opinion of the Investigator, makes the subject unsuitable for inclusion in the study.
  • Body Mass Index (BMI) \<=16.0 kg/m2 or \>=40.0 kg/m2
  • A current or history of significant gastrointestinal motility problems
  • A positive test for HIV 1 and 2 antibodies
  • A history of substance or alcohol abuse within the last year.
  • Seizure disorders
  • A history of drug or other allergy
  • A temporary catheter as a vascular access
  • Participated in a clinical study with any experimental medication in the last 30 days or an experimental biological product within the last 90 days prior to signing of informed consent

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2009

Estimated Enrollment :

336 Patients enrolled

Trial Details

Trial ID

NCT00416520

Start Date

June 1 2007

End Date

November 1 2009

Last Update

January 8 2026

Active Locations (68)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (68 locations)

1

Adelaide, Australia

2

Nedlands, Australia

3

Parkville, Australia

4

St Leonards, Australia